Lam Research (LRCX) SVP gets 53,925 shares from performance stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lam Research senior vice president Varadarajan Seshasayee acquired 53,925 shares of common stock on 02/03/2026 through the exercise of market-based performance restricted stock units at $0 per share. Following the transaction, he directly beneficially owned 249,564 common shares, including shares subject to unvested restricted stock units, and indirectly held 2,366.932 shares through a 401(k) plan.
The exercised award originally covered 35,950 market-based performance restricted stock units granted on 03/01/2023, with vesting tied to Lam Research total shareholder return versus the PHLX Semiconductor sector index over a performance period from 02/01/2023 through 01/31/2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
35,950 shares exercised/converted
Mixed
3 txns
Insider
Varadarajan Seshasayee
Role
Senior Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Market-based Performance Restricted Stock Unit | 35,950 | $0.00 | -- |
| Exercise | Common Stock | 53,925 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Market-based Performance Restricted Stock Unit — 0 shares (Direct);
Common Stock — 249,564 shares (Direct);
Common Stock — 2,366.932 shares (Indirect, By 401(k))
Footnotes (1)
- On 03/01/2023, the Reporting Person received a grant of 35,950 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2026. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2023 through 01/31/2026. The amount reported includes shares subject to unvested restricted stock units. The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.
FAQ
What insider transaction did Lam Research (LRCX) report for Varadarajan Seshasayee?
Lam Research (LRCX) reported that senior vice president Varadarajan Seshasayee acquired 53,925 shares of common stock on 02/03/2026. The shares came from exercising market-based performance restricted stock units at $0 per share, reflecting equity compensation vesting.
What type of equity award vested for Lam Research (LRCX) executive Varadarajan Seshasayee?
The award was a grant of 35,950 market-based performance restricted stock units. Vesting depends on Lam Research total shareholder return versus the PHLX Semiconductor Total Return Index over a performance period running from 02/01/2023 through 01/31/2026, with vesting between 0% and 150%.
When were the performance stock units originally granted to the Lam Research (LRCX) executive?
The market-based performance restricted stock units were originally granted on 03/01/2023. This grant covers 35,950 units whose vesting is tied to Lam Research’s total shareholder return compared with the PHLX Semiconductor sector index over a defined multi-year performance period.
How is vesting determined for Lam Research (LRCX) market-based performance restricted stock units?
Vesting for these units is based on Lam Research total shareholder return relative to the PHLX Semiconductor Total Return Index. The performance comparison uses a 50-trading-day trailing average closing price over the period from 02/01/2023 to 01/31/2026, with vesting between 0% and 150%.
Does the Lam Research (LRCX) Form 4 show any indirect holdings for the reporting person?
Yes. In addition to directly owned shares, the Form 4 shows 2,366.932 common shares held indirectly in a 401(k) plan. These indirect holdings are reported separately from the 249,564 shares beneficially owned directly, which include unvested restricted stock units.